title: Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients.
authors.forename: Arduino
authors.initials: A
authors.lastname: Arduini
authors.forename: Mario
authors.initials: M
authors.lastname: Bonomini
authors.forename: Elaine J
authors.initials: EJ
authors.lastname: Clutterbuck
authors.forename: Michael A
authors.initials: MA
authors.lastname: Laffan
authors.forename: Charles D
authors.initials: CD
authors.lastname: Pusey
mesh_terms: D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D002331:Carnitine / Q000008:administration & dosage* / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D004912:Erythrocytes / Q000187:drug effects*; D005500:Follow-Up Studies; D006400:Hematocrit; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D006435:Renal Dialysis; D016896:Treatment Outcome; D014511:Uremia / Q000150:complications / Q000628:therapy*; D014803:Vitamin B Complex / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D014803:Vitamin B Complex; D002331:Carnitine